Editorial: Targeted Immunological Therapies in Dermatology

This editorial discusses the potential of targeted immunological therapies in dermatology, focusing on chronic inflammatory diseases like eczema and psoriasis. Traditional treatments with corticosteroids have significant side effects, prompting the exploration of alternatives such as biologics, small-molecule inhibitors, and RNA-based therapeutics. The research highlights the role of the immune environment in disease pathogenesis and evaluates various immunotherapies for conditions like alopecia areata, psoriasis, and melanoma. Notably, JAK inhibitors and monoclonal antibodies are emphasized for their precision and reduced side effects. The studies underscore a shift towards more effective and safer dermatological treatments, marking a significant advancement in the field.